Charlie cofounded Parse Biosciences and leads as its Chief Technology Officer. Charlie is passionate about biology-based technology development, with over a decade of driving innovation in the field. Prior to Parse, he studied at the University of Washington, where he received several fellowships from the National Institutes of Health and Fred Hutch Cancer Research Center. This work generated high-profile publications in Science and informed the core technology of Parse Biosciences. Previously, Charlie contributed to innovations in drug delivery and microscopy at the Wyss Institute at Harvard and the University of Pennsylvania.